Scapho
Brand Name: Scapho®
Composition: Secukinumab (150 mg/ml Powder for solution for injection)
Product Description
Medical Info
Scapho® contains Secukinumab, a targeted biologic medication formulated as a powder to be reconstituted into a solution for subcutaneous injection. It belongs to a class of drugs known as interleukin inhibitors, specifically targeting and neutralizing the IL-17A protein, which plays a central role in driving inflammatory responses. By inhibiting this pathway, Scapho® effectively reduces the systemic inflammation associated with chronic autoimmune conditions like plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Each single-use vial delivers a precise 150 mg dose, helping patients manage symptoms, prevent joint damage, and achieve clearer skin under professional medical supervision.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
